Assessment of the Immunization Levels Against Sars-Cov2 Virus in Subjects Who Have Received EU-approved COVID-19 Vaccines

Patients who voluntarily visit vaccination centers in Greece against COVID-19 are recruited and their immunization levels against Sars-Cov2 are assesed by measurement of the levels of serum antibodies against Sars-cov-2 before vaccination and in time intervals up to 6-9 months post-vaccination (indicatively 0-1-3-6-9 months post-vaccination).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

SARS-CoV2 Infection COVID-19 Coronaviridae Infections Coronavirus Infections Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Vaccine Reaction Virus Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital of Patras

Pátrai, 26504, Greece

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Subjects who voluntarily receive COVID-19 vaccination

Exclusion criteria

Patients who do not complete their vaccination
Patients who do not provide info on their health status

Treatment and study plan

Approved vaccines against Sars-Cov2

Biological

Subjects who voluntarily are vaccinated against Sars-Cov-2 with any of the approved vaccines by EU

Primary outcomes

Antibody titer against Sars-Cov2

Time frame: 0-9 months

Sponsors and collaborators

Lead sponsor

University of Patras

Other

Registry information

Official study title

Assessment of the Immunization Levels Against Sars-Cov2 Virus in Subjects Who Have Received European Union (EU) -Approved COVID-19 Vaccines

Important dates

Study start: 2021
Primary completion: 2022
Study completion: 2022
First posted: Jul 8, 2021
Registry last updated: Jun 6, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed